Company Description
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.
The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.
This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans.
The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials.
The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services.
It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers.
The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Country | United States |
Founded | 1984 |
IPO Date | Dec 13, 2001 |
Industry | Healthcare Plans |
Sector | Healthcare |
Employees | 60,500 |
CEO | Sarah London |
Contact Details
Address: Centene Plaza, 7700 Forsyth Boulevard Saint Louis, Missouri 63105 United States | |
Phone | 314 725 4477 |
Website | centene.com |
Stock Details
Ticker Symbol | CNC |
Exchange | NYSE |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001071739 |
CUSIP Number | 15135B101 |
ISIN Number | US15135B1017 |
Employer ID | 04-1406317 |
SIC Code | 6324 |
Key Executives
Name | Position |
---|---|
David P. Thomas | Chief Executive Officer of Markets and Medicaid |
Sarah M. London | Chief Executive Officer and Director |
Kenneth John Fasola | President |
Andrew Lynn Asher | Executive Vice President and Chief Financial Officer |
Christopher Andrew Koster | Executive Vice President, General Counsel and Secretary |
Susan R. Smith | Chief Operating Officer |
Katie Nicole Casso | Senior Vice President of Finance, Corporate Controller and Chief Accounting Officer |
Brian Phillip LeClaire M.B.A., Ph.D. | Chief Information Officer |
Jennifer Lynch Gilligan | Senior Vice President of Investor Relations |
Ashlee Knuckey | Chief Risk, Ethics and Compliance Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Mar 27, 2025 | DEF 14A | Other definitive proxy statements |
Mar 21, 2025 | 144 | Filing |
Mar 12, 2025 | 8-K | Current Report |
Mar 5, 2025 | 8-K | Current Report |
Mar 3, 2025 | 8-K | Current Report |
Feb 24, 2025 | 8-K | Current Report |
Feb 18, 2025 | 10-K | Annual Report |
Feb 11, 2025 | SCHEDULE 13G | Filing |
Feb 4, 2025 | 8-K | Current Report |